CClinicalTrials.gg
CompletedNCT02779244Updated Nov 3, 2023

Early Weight Bearing for Unstable Ankle Fractures Undergoing Operative Stabilization

An interventional study of Early Weight bearing + Cam Boot and Non-Weight Bearing + Cam Boot in Ankle Fracture, sponsored by NYU Langone Health. Completed at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2023-11-03.

Sponsored by NYU Langone Health · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
107
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The purpose of this randomized, controlled trial is to estimate the safety of early weight bearing on post ankle surgery.

Patients who are indicated to have surgery for unstable ankle fractures by an attending trauma physician will be consented for participation in the study. After surgery patients will be randomized to either weight bearing as tolerated at two weeks with a cam boot or non-weight bearing with a cam boot. Randomization will be performed by number allocation with odd numbers in the early weight bearing group and even numbers in the non-weight bearing group. The surgeon will be blinded to this until after the surgery. The patients will all be placed in a short leg cast post operative and made non-weight bearing for 2 weeks until sutures are removed which is current standard treatment. Both groups will be asked to initiate weight bearing at two weeks post operatively by wearing a cam boot that is non weight bearing in a cam boot, the latter being standard treatment.

02

Conditions studied

  • Ankle Fracture

Keywords

  • Orthopedic
  • Post-operative
  • Weight bearing
  • Range of motion
03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's enrollment of 107 is above the median of 69 across 1,482 interventional studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

NYU Langone Health is the lead sponsor of 1,391 studies on the registry; 254 are open to participants now.

Of its 227 completed or terminated interventional studies of FDA-regulated products, 191 (84%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Operative unstable ankle fractures

Exclusion criteria

Exclusion Criteria:

  • Requirement of syndesmotic fixation
  • Pilon fractures
  • Open fractures
  • Patients with diabetic neuropathy
  • BMI>40
  • Polytrauma patients
  • Patients who are unable to comply with non-weight bearing
  • Patients who are unable to follow up
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Care provider)
Enrollment
107 participants (actual)

Study arms

  • Experimental
    Early Weight Bearing + Cam boot

    Procedure: Early Weight bearing + Cam Boot

  • Active comparator
    Standard Treatment Cam boot

    Procedure: Non-Weight Bearing + Cam Boot

Interventions

  • ProcedureEarly Weight bearing + Cam Boot

    Patients will be transitioned to weight bearing as tolerated in a cam boot.

  • ProcedureNon-Weight Bearing + Cam Boot

    Subject will be transitioned to non weight bearing cam boot, standard treatment.

06

What researchers measure

Primary outcomes

  1. Olerud Molander Ankle Score

    The Olerud Molander score is scored between 0 - 100 as painless and functionally perfect ankle.

    Time frame: 1 year

07

Study locations

1 site
  • New York University Langone Medical Center
    New York, New York 10016, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02779244
Lead sponsor
NYU Langone Health
Responsible party
Sponsor
First posted
May 20, 2016
Start date
Sep 1, 2017
Primary completion
Jun 14, 2022
Completion
Jul 1, 2023
Last update
Nov 3, 2023

Study contacts

Nirmal Tejwan, MD
principal investigator · NYU Langone Health

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion